Full Text View
Tabular View
No Study Results Posted
Related Studies
An RCT of Metformin Vs Orlistat in Obese Anovulatory Women
This study has been completed.
Study NCT00292799   Information provided by Sheffield Teaching Hospitals NHS Foundation Trust
First Received: February 15, 2006   Last Updated: July 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anovulation
Obesity
More general conditions related to this trial
Adnexal Diseases
Body Weight
Endocrine System Diseases
Genital Diseases, Female
Gonadal Disorders
Nutrition Disorders
Ovarian Diseases
Overnutrition
Overweight
Signs and Symptoms
Interventions listed in this trial
Orlistat Vs Metformin
Additional drug interventions recognized in this trial
Metformin
Orlistat
More general drug interventions related to this trial
Anti-Obesity Agents
Central Nervous System Agents
Enzyme Inhibitors
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Sheffield Teaching Hospitals NHS Foundation Trust


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services